← Open Payments lookup

BRIAN KELTY: Open Payments

NPI 1124462221 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$879 in 53 payments from 14 companies in 2025. Trend: 2023 $926 · 2024 $727 · 2025 $879

Food & beverage: $879
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$197
Otsuka America Pharmaceutical, Inc.12$141
Vanda Pharmaceuticals Inc.3$92
ABBVIE INC.4$82
Axsome Therapeutics, Inc.3$79
Collegium Pharmaceutical, Inc.4$66
Alkermes, Inc.2$46
Takeda Pharmaceuticals U.S.A., Inc.2$39
Sage Therapeutics, LLC2$31
Neos Therapeutics, LP2$28

Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, Auvelity, Jornay PM, ARISTADA, TRINTELLIX.

Industry payments across KY — which companies pay providers there.